New SEC Form D filing

Pelthos Therapeutics Inc., 2026-11-16

A new SEC Form D private-offering notice from Durham, NC, a $57,500,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Pelthos Therapeutics Inc. site↗ Verified via SEC Form D

Commercial stage biopharmaceutical company developing treatments for cutaneous infectious diseases, including its lead product Zelsuvmi for molluscum contagiosum

Filed 3 days agoFiled to raise $57,500,000First money in 2026-10-30Raised so far $57,500,000HQ (as filed) Durham, NCSector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified pelthos.com↗Named in the filing 10 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source